![STOCKTALK CENTRAL SPECIAL ALERT]() |
| NEWS ALERT! |
| IBXG Group, Inc. (OTCBB:
IBXG) |
Near Term
Price Projection: $.38 |
|
| SHARES
OUTSTANDING: |
50 million |
| APPROX.
FLOAT: |
20
million |
| Near Term Price Proj.:
|
$.38 |
|
| A Few
Reasons To Own IBXG |
|
- IBXG is an emerging growth company in the trillion-dollar healthcare industry.
- IBXG is coming off its fourth quarter in a row of increasing revenues and its second
consecutive profitable quarter. IBXG experienced a 50% gain in third quarter revenue.
- IBXG estimated EPS for all of 2002 is estimated to be $.01 per share.
- IBXG is currently cash flow positive. IBXG is making acquisitions and expanding its
infrastructure while vigorously pursuing the Marketing Plan.
- IBXG is a results-oriented company with three integrated divisions - Healthcare
Transaction Services, Physical Therapy & Occupational Medicine, and Technology/Information Services.
- IBXG has established a strong market niche in the area of Healthcare Transaction
Services.
- IBXG recently began managing its largest receivables management project ever totaling
$39 million from Intracoastal Health Systems, Inc. of West Palm Beach, Florida.
- IBXG has implemented a clear-cut strategic plan to expand its capabilities in the area of
Physical Therapy and Occupational Medicine.
- IBXG has developed and recently commenced marketing an innovative web-based
inventory management application for the $1.5 billion durable medical equipment (DME) industry.
- IBXG has developed and deployed a proprietary online consumer medical records
service throughout the U.S. The technology is being utilized by several affinity groups, including one of the
largest credit card companies in the world.
- IBXG's internal compliance program has been certified as meeting all current
requirements of the Federal Health Insurance Portability and Accountability Act (HIPAA).
|
|
|
Great
News! "Timing, Timing, Timing" is Another KEY INGREDIENT TO THE SUCCESS FOR ANY
BUSINESS.
In our
Last Profile we spoke about Management being one of the KEY INGREDIENTS TO THE SUCCESS FOR
ANY BUSINESS and That it Appeared to Us That The Company had The Real McCoy's as Part of The
Management Team to Help Lead IBXG into The Future.
It now
appears that IBXG's MediCompliant Solutions Division is Right on Time and Ready to Help Healthcare
Organization's comply with the Federal Department of Health and Human Services New Privacy Rules and
Deadline to Comply as of This October.
As
stated in The PR, what this Means to IBXG is Increased Revenues of $1.5 Million Dollars to Over $2 Million
Dollars.
As
Quoted from the PR:
"Since
these requirements are so complex, many healthcare organizations have chosen to consult legal professionals
such as MediCompliant Solutions to determine how their daily operations will be impacted. And with the
comprehensive security regulations on the horizon, there is no doubt that healthcare organizations will need
professional consultation more than ever."
Well
When you "Mix The Stew", Timing and Management, you Should Surely Have A Winning Combination That
Should Make IBXG's Shareholder's Very Happy in The Near Term.
WE CONTINUE TO MAKE THIS ARGUMENT:
According to a March 17th, 2003 PR from IBXG whereby IBXG raised revenue guidance for this year
from $11 Million Dollars to $14 Million Dollars, and since then has announced Additional Revenue Deals
such as today's PR, there has been virtually NO CHANGE IN IBXG's STOCK PRICE.
If we now compare IBXG to its peers, the peer group trades in the marketplace (according to
Multex) at 27 times earnings and about 6 times sales, then applying these multiples to IBXG on an EPS basis
IBXG should be worth TODAY $.47 Per Share, and on a multiple of sales IBXG should be worth TODAY
almost $1.45 Per Share.
IBXG's
Market Cap is about $6 Million Dollars with estimating $14 Million Dollars Plus in Revenues for 2003, and
expecting to Earn over $1 Million Dollars.
IN OUR OPINION, AT CURRENT STOCK PRICE LEVELS IBXG IS GROSSLY
UNDERVALUED, AND WE BELIEVE IS DO FOR A POP TO HIGHER STOCK MARKET
VALUATION'S AND HOPEFULLY SOON.
So, it
appears to us that the IBXG PR Machine is once again in Full Motion.
So keep
a Real, Real Close Eye on IBXG as we think MORE PR IS LIKELY FORTHCOMING, and as always,
Watch
This Stock Trade.
|
|
MEDICOMPLIANT SOLUTIONS EXPECTS INCREASED DEMAND AS
GOVERNMENT BEGINS HIPAA INVESTIGATIONS, INCREASES SALES
PROJECTIONS DEERFIELD
BEACH, Fla., Sept. 19, 2003 - With another deadline for the Health Insurance and Accountability Act
(HIPAA) quickly approaching, iBX Group, Inc. (OTC Bulletin Board: IBXG), is preparing for an influx of new
clients for its MediCompliant Solutions division, a healthcare legal services organization specializing in
HIPAA and Medicare compliance. IBX has increased revenue projections for MediCompliant Solutions, set
forth earlier this year, at $1.5 million to over $ 2 million. Sales of the web-based compliance data application
have doubled in the third quarter.
The federal
Department of Health and Human Services has said it will begin investigating alleged violations of HIPAA's
strict patient privacy provisions in October. The privacy rules, which took effect in April, require healthcare
providers to safeguard the integrity of the Protected Health Information of all patients.
The stakes of this
legislation are particularly high, according to Lauren A. Cohen, Esq., Managing Director for MediCompliant
Solutions. Failure to meet the new standards could result in severe financial penalties, possible criminal
sanctions and even exclusion from Medicare and other federally subsidized programs. Conforming to the
regulations will cost the private and public sectors an estimated $22 billion in the coming years, according to
the government's own estimates.
"There's been a
great deal of confusion in the medical community about what will constitute a violation of HIPAA's privacy
regulations," Cohen said. "Since these requirements are so complex, many healthcare organizations have
chosen to consult legal professionals such as MediCompliant Solutions to determine how their daily operations
will be impacted. And with the comprehensive security regulations on the horizon, there is no doubt that
healthcare organizations will need professional consultation more than ever."
Also in October,
new national standards for electronic billing will take effect. Any provider who has not implemented the
necessary software upgrades or who continues to use incorrect billing codes will have their Medicare claims
rejected.
In addition to
providing legal consultation for healthcare organizations, MediCompliant Solutions is also working to develop
several products that will help providers create "paperless" offices, as well as document their compliance with
HIPAA and other regulations. "One of the most promising products we're working on is a device that will
electronically capture patients' acknowledgements of the practice's HIPAA privacy procedures," Cohen said.
"The information it stores will work in conjunction with the organization's Electronic Medical Records (EMR)
system and may help providers avoid costly government investigations and penalties."
Based in Deerfield
Beach, Florida, iBX Group Inc. develops and deploys creative, cost-effective methods for integrating financial,
administrative and information services for the healthcare industry. iBX is a results-oriented company,
consisting of five divisions - iBX Technologies, which enables healthcare organizations to maximize their
accounts receivables; Florida HealthSource, a network of physical therapy and wellness centers;
MediCompliant Solutions, which ensures medical practices' compliance with today's complex legal
requirements; iBX Transcription Services, which offers physicians quick turn-around and Web-accessible
progress reports; NursesSTAT, a revolutionary temporary staffing solution. IBX also owns
SportshealthNet.com and TheNetDigest.com, interactive Web portals providing patients with comprehensive
healthcare information and advice, and increasing physician referrals.
This release is
comprised of interrelated information that must be interpreted in the context of all of the information provided
and care should be exercised not to consider portions of this release out of context. This release contains
certain "forward-looking statements and information" (as defined in the Private Securities Litigation Reform
Act of 1995) concerning iBX Group, Inc. that are based on the beliefs of iBX Group, Inc.'s management, as
well as assumptions made by and information currently available to iBX Group, Inc. Investors are cautioned
that all forward-looking statements involve risks and uncertainties, including those risks and uncertainties
detailed in iBX's filings with the Securities and Exchange Commission.
|
|
|
A Penny
Stock with Multi-Dollar Potential: Trading Today in the Teens, but in our opinion, has Near-Term Potential
for Huge Gains. IBXG may be one This Year's BIG surprises, making its current status as an undiscovered
stock a rare timing opportunity for investors. Don't overlook this one! We not only consider IBXG an
attractive "Emerging Growth Company," in our opinion, but also a "Value Stock" in view of its Revenues and
Earnings. We believe that IBXG has targeted a creative niche in a hot sector.
Relative
to comparative companies within the Healthcare Sector, IBXG could realize superior growth in business and
earnings over the Near- Term period. A grouping of comparable companies within this Sector currently trades
at an average price to revenues multiple of 6.19 X. For 2003 it is now estimated that IBXG should generate
revenues of about $15 MILLION DOLLARS, and EPS of $0.02 Per Share.
If over
the Near-Term IBXG were to trade in the Market Place at a 80% Discount to its Peers, then applying the
comparative grouping's price to revenue multiples to IBXG we can arrive at a relative valuation of $.38 per
share over the Near-Term.
|
|
|
"Patients
want to do more of their medical management from home, doctors want to provide care quickly and efficiently,
and hospitals and HMO’s want to keep costs down," says Jim Gabler, a research director for
GartnerGroup’s Healthcare Industry Research and Advisory Services in Stamford, Conn. "All
of this relates to technology, and it’s up to CIO’s to find a better way. People say healthcare
revolves around doctors and patient care. Well in the months and years to come, the industry will revolve
around technology and the CIO."
Given this climate
in healthcare today, in our opinion, IBXG is an undervalued opportunity. IBXG is perfectly positioned to meet
the needs of their target market with a strong commitment to their suite of services.
Aggressive
investors looking for above-average return potential on a portion of their investment capital should give IBXG
a serious look.
|
|
|
Are you a CEO
of a Public Company or the Head of an Investor Relations or Public Relations Firm interested in Advertising
your Company, or do you have a Product or Service that you would like Advertised to what we believe is the
most Qualified & Largest Permission Based Opt-in Membership in the World, demographically
speaking.
Unlike any
other Email Marketer in the World, we can Guarantee Your Advertisement to be Opened and Read by over 1
Million of our Membership within 12 Hours of when we start to send Emails. We believe no other Email
Marketer in the World can make this claim.
Yes, that’s right
Guaranteed and Verified by what we believe is the Most Sophisticated Tracking Software in the World. Don’t
be confused with other offers to Send Million’s of Emails as opposed to our offer whereby over 1 Million of
our Members actually Open and Read Your Advertisement within 12 Hours of when we start to send emails,
and many more thereafter.
We Don’t
Come Cheap! We charge a premium for our services. So, only serious inquiries need to reply. If you are
interested in learning more about our services, please click here
and provide us with your contact information and some detail of what you are looking to advertise. If we are
interested one of our representative’s will contact you shortly.
|
Disclaimer:
The purpose of this advertisement is to provide publicity for the advertised company, its products or
services. This advertisement is not a solicitation or recommendation to buy, sell or hold securities and does
not provide an analysis of the financial position of the company. StockTalk Central, and affiliates (STC),
publishes reports providing information on selected companies that STC believes has investment potential.
STC is not a registered investment advisor or broker-dealer. The above report is the opinion of STC and is
not a guarantee that the target price for the stock will be met or that predicted business results for the
company will occur. This report is provided as an information service only, and the statements and opinions in
this report should not be construed as an offer or solicitation to buy or sell any security. STC accepts no
liability for any loss arising from an investor's reliance on or use of this report. An investment in IBXG is
considered to be highly speculative and should not be considered unless a person can afford a complete loss of
investment. Previously, an affiliate of STC has been compensated one hundred forty-five thousand dollars by
the company, and additionally received 7.2 million warrants exercisable into free trading shares of common
stock of IBXG at ten cents per share and an additional 1 million warrants exercisable into free trading shares
of common stock of IBXG at thirteen cents per share and an additional 2 million warrants exercisable into free
trading shares of common stock of IBXG at five cents per share by a third party for the publication and
circulation of previous reports, of which all the warrants have been exercised and the stock sold. In addition,
IBXG has extended their agreement for the publication and circulation of this report, and an affiliate of STC
has been compensated one hundred thousand dollars and received an additional 2 million warrants exercisable
into free trading shares of IBXG at ten cents per share by a third party non-affiliate (TFST) and STC and
affiliates have no relationship whatsoever to the third party. STC intends to sell all or a portion of the IBXG
stock at or about the time of publication of this report. Subsequently STC may buy or sell shares of IBXG
stock in the open market. Since an affiliate of STC has been compensated there is an inherent conflict of
interest. This report contains forward-looking statements, which involve risks, and uncertainties that may
cause actual results to differ materially from those set forth in the forward-looking statements. For further
details concerning these risks and uncertainties, see the SEC filings of IBXG including the company's most
recent annual and quarterly reports.
|
|
|
